Labcorp Announces 2025 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'
October 28, 2025 1:09 PM EDTLeerink Partners analyst Michael Cherny reiterated an Outperform rating and $342.00 price target on Laboratory Corporation of America (NYSE: LH).
The analyst comments "We remain positive on LH and view the pronounced weakness post-Q as an opportunity for a durable compounder at a more appealing valuation. As we... More
Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance
October 28, 2025 6:51 AM EDTLabcorp (NYSE: LH) reported Q3 EPS of $4.18, $0.05 better than the analyst estimate of $4.13. Revenue for the quarter came in at $3.56 billion versus the consensus estimate of $3.56 billion.
GUIDANCE:
Labcorp sees FY2025 EPS of $16.15-$16.50, versus the consensus of $16.30.
For earnings history and earnings-related data on Labcorp (LH) click here.
... More


